The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats
Open accessAbstract
BACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri isolated from diabetes resistant rats to determine the effect on type 1 diabetes development. METHODOLOGY/PRINCIPAL: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1 diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L. johnsonii fed animals low levels of the pro-inflammatory cytokine IFNgamma were correlated with low levels of iNOS and high levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin. CONCLUSIONS: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Mack, D. R., Michail, S., Wei, S., McDougall, L., & Hollingsworth, M. A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g941 · Cited by 829
Guo, X., Xia, X., Tang, R., Zhou, J., Zhao, H., & Wang, K. (2008) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2008.02408.x · Cited by 505
The “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Self-citationKamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Epithelial Tight Junctions in Intestinal Inflammation
Schulzke, J. D., Ploeger, S., Amasheh, M., Fromm, A., Zeissig, S., Troeger, H., Richter, J., Bojarski, C., Schumann, M., & Fromm, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04062.x · Cited by 399
Quantitative Analysis of Diverse Lactobacillus Species Present in Advanced Dental Caries
Byun, R., Nadkarni, M. A., Chhour, K.-L., Martin, F. E., Jacques, N. A., & Hunter, N. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3128-3136.2004 · Cited by 382
Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
Brugman, S., Klatter, F. A., Visser, J. T. J., Wildeboer-Veloo, A. C. M., Harmsen, H. J. M., Rozing, J., & Bos, N. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0334-0 · Cited by 332
Cited by
Toward defining the autoimmune microbiome for type 1 diabetes
Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806
Self-citationBrown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025792 · Cited by 778
Self-citationMurri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo-Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 765
Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease
Brown, K., DeCoffe, D., Molcan, E., & Gibson, D. L. (2012) · Nutrients · doi:10.3390/nu4081095 · Cited by 676
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
Musso, G., Gambino, R., & Cassader, M. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012510-175505 · Cited by 598
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
Fecal Microbiota Composition Differs Between Children With β-Cell Autoimmunity and Those Without
de Goffau, M. C., Luopajärvi, K., Knip, M., Ilonen, J., Ruohtula, T., Härkönen, T., Orivuori, L., Hakala, S., Welling, G. W., Harmsen, H. J., et al. (2013) · Diabetes · doi:10.2337/db12-0526 · Cited by 557
Gut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
Chen, K., Chen, H., Faas, M. M., de Haan, B. J., Li, J., Xiao, P., Zhang, H., Diana, J., de Vos, P., & Sun, J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601006 · Cited by 458
Fujimura, K. E., Demoor, T., Rauch, M., Faruqi, A. A., Jang, S., Johnson, C. C., Boushey, H. A., Zoratti, E., Ownby, D., Lukacs, N. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310750111 · Cited by 422
Gut microbiota, probiotics and diabetes
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363
Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex
Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.008 · Cited by 331
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Ma, T., Shen, X., Shi, X., Sakandar, H. A., Quan, K., Li, Y., Jin, H., Kwok, L.-Y., Zhang, H., & Sun, Z. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.06.013 · Cited by 329
The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes
Devaraj, S., Hemarajata, P., & Versalovic, J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.187617 · Cited by 321
Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity
Brown, E. M., Kenny, D. J., & Xavier, R. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041841 · Cited by 312
Davis-Richardson, A. G., Ardissone, A. N., Dias, R., Simell, V., Leonard, M. T., Kemppainen, K. M., Drew, J. C., Schatz, D., Atkinson, M. A., Kolaczkowski, B., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00678 · Cited by 308
Self-citationTh17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
Self-citationReynolds, L. A., Smith, K. A., Filbey, K. J., Harcus, Y., Hewitson, J. P., Redpath, S. A., Valdez, Y., Yebra, M. J., Finlay, B. B., & Maizels, R. M. (2014) · Gut Microbes · doi:10.4161/gmic.32155 · Cited by 258
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 257
Gut Microbiota and Type 1 Diabetes
Han, H., Li, Y., Fang, J., Liu, G., Yin, J., Li, T., & Yin, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040995 · Cited by 206
“An increasing number of studies indicate that in BB-DP rats, increased intestinal permeability allows unregulated passage of environmental antigens, which can induce the autoimmune response and subsequently promote the development of T1D [20,40].”
BackgroundInfluentialLuca, M., Di Mauro, M., Di Mauro, M., & Luca, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4730539 · Cited by 190
“Other studies have reported that SCFAs are also associated with a reduction of telomere shortening and DNA damage by altering chromatin structures and inducing the production of the antioxidant glutathione [28] and increasing COX-2 activity [29].”
BackgroundProbiotics and prebiotics for the amelioration of type 1 diabetes: Present and future perspectives
Mishra, S., Wang, S., Nagpal, R., Miller, B., Singh, R., Taraphder, S., & Yadav, H. (2019) · Microorganisms · doi:10.3390/microorganisms7030067 · Cited by 131
“reuteri did not release any of this protein [82].”
BackgroundProbiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis
Samah, S., Ramasamy, K., Lim, S. M., & Neoh, C. F. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.014 · Cited by 112
Time to include the gut microbiota in the hygienic standardisation of laboratory rodents
Bleich, A., & Hansen, A. K. (2012) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.006 · Cited by 82
Consumption of Acidic Water Alters the Gut Microbiome and Decreases the Risk of Diabetes in NOD Mice
Wolf, K. J., Daft, J. G., Tanner, S. M., Hartmann, R., Khafipour, E., & Lorenz, R. G. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413519650 · Cited by 76
Wirth, R., Bódi, N., Maróti, G., Bagyánszki, M., Talapka, P., Fekete, É., Bagi, Z., & Kovács, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110440 · Cited by 69
Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet
Calabrese, C. M., Valentini, A., & Calabrese, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.612773 · Cited by 58
Metadata
- Authors
- Valladares, R., Sankar, D., Li, N., Williams, E., Lai, K.-K., Abdelgeliel, A. S., Gonzalez, C. F., Wasserfall, C. H., Larkin, J., Schatz, D., Atkinson, M. A., Triplett, E. W., Neu, J., & Lorca, G. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-06
- Volume
- 5
- Issue
- 5
- Pages
- e10507
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2042148950
- Cited by
- 279
- References
- 41
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.